Archean Chemical Industries Ltd.NSE: ACI

ACI: FY26 saw modest revenue growth, margin pressure, and strategic expansion into semiconductors

· Issued by Archean Chemical Industries Ltd.

FY26 revenue grew 3% YoY, but Q4 saw a 13% decline due to Industrial Salt moderation. EBITDA and PAT fell YoY, impacted by logistics costs and technical downtime in Bromine. Strategic moves include semiconductor and energy storage expansion.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Archean Chemical Industries

All Archean Chemical Industries news releases